Immunosuppression in a lung transplant recipient with COVID-19? Lessons from an early case

Respir Med Res. 2020 Nov:78:100782. doi: 10.1016/j.resmer.2020.100782. Epub 2020 Aug 3.
No abstract available

Keywords: Immunosuppressants; Lung transplantation; Protease inhibitors; SARS-CoV-2; Therapeutic drug monitoring.

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • COVID-19 Drug Treatment*
  • Humans
  • Immunosuppression Therapy
  • Lopinavir
  • Lung
  • Pandemics
  • Ritonavir
  • SARS-CoV-2
  • Transplant Recipients*

Substances

  • Lopinavir
  • Ritonavir